Skip to content

Pulse Biosciences

US · PLSE #2388 by market cap Listed 2016
49.09 -0.66 -1.33%
Live - 5344 symbols - heartbeat 130s ago · 2026-10-08 08:06
Pre-market 48.85 -0.49%
After-hours 49.09 0.00%
Market cap
3.50B
P/B
35.19
EPS
-1.08
Reader sentiment Are you bullish or bearish on PLSE?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/8/10
  • Needham Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $58
    Market Newswire · 2026/8/17
  • BTIG Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $70
    Market Newswire · 2026/9/23
  • Freedom Capital Markets Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $73
    Market Newswire · 2026/9/9
  • Rating change
    Oppenheimer Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $22
    Market Newswire · 2025/7/8
  • Rating change
    Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $22
    Market Newswire · 2025/11/6
  • CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $43
    Market Newswire · 2026/8/12
  • Rating change
    Mizuho Securities Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $25
    Market Newswire · 2026/1/30
  • Rating change
    Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $30
    Market Newswire · 2026/4/13
  • Rating change
    Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2026/7/28
  • Rating change
    Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $30
    Market Newswire · 2026/2/6
  • Rating change
    Oppenheimer Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $30
    Market Newswire · 2026/2/20
  • Rating change
    CCORF Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $32
    Market Newswire · 2026/6/4
  • Rating change
    CCORF Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Raises Target Price to $43
    Market Newswire · 2026/8/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:06:51 · For reference only, not investment advice and not tailored to your situation.